Location: Home
  • search
  • go
  • Relate News
  • 4/12/2021Review of R&D Spending of Listed Chinese Biopharma Firms 2018-2020
  • 4/12/2021NMPA Accepts NDA for Ocumension's OT-401 (YUTIQ) on Real World Data
  • 4/12/2021Sorrento Therapeutics To Buy ACEA Therapeutics For $38M in Stock
  • 4/12/2021NMPA Outlines Process and Prospects of ICH in China at Latest Symposiu...
  • 4/12/2021CDE Solicits Comments on Proposed Technical Guidelines for BE Study of...
  • 4/12/2021PharmaDJ's China Biotech Fundraising Tracker: Feb 2021
  • 4/12/2021FiercePharma: BeiGene Details Novartis-partnered PD-1's First Global P...
  • 4/9/2021NMPA Issues the List of Reference Formulations for GQCE Studies (40th ...
  • 4/9/2021Recent Executive Moves
  • 4/8/2021Clinigen Launches Managed Access Program with BeiGene for Zanubrutinib
  • 4/8/2021China to Improve BMI Outpatient Coverage As It Reforms Individual Acco...
  • 4/8/2021NHC Issues Notice to Strengthen Management of Microbial Drugs to Conta...
  • 4/8/2021China Introduces New Preferential Policies in Hainan to Boost Sectors ...
  • 4/8/2021Biogen and Bio-Thera Solutions Announce License Deal for Actemra Biosi...
  • 4/8/2021BeiGene's Guangzhou Biologics Plant Granted First Commercial Manufactu...
  • 4/8/2021BeiGene Launches BRUKINSA® (Zanubrutinib) in Canada for Waldenström'...
  • 4/8/2021China's 14th Five-Year Plan (2021-2025): Signposts for Doing Business ...
  • 4/8/2021MNCs Rethink China Strategy as New Opportunities Emerge in Special Zon...
  • 4/7/2021Shanghai Henlius Biotech Maps Out Its Biosimilars Future
  • 4/7/2021Antengene Granted Chinese IND Approval for ATG-019 Clinical Trial
  • 4/7/2021Chime Bio Builds Second Biomanufacturing Facility in Wuhan After Rais...
  • 4/7/2021China Set to Initiate 5th Round of National Level Centralized VBP of D...
  • 4/6/2021Crystec Launches New R&D Center in China
  • 4/6/2021HitGen and BioAge Announce Research Progress in DNA-Encoded Library Ba...
  • 4/6/2021NMPA Announces Package Insert Revision of Amikacin Injection and Cefur...
  • 4/6/2021Snapshot of New Chinese biopharma IPOs 2019-2020
  • 4/6/2021iX Biopharma Enters Cooperation Deal with China Resources Pharma Comme...
  • 4/6/2021A Stronger Protection of Trade Secret in China
  • 4/5/2021PharmaDJ's China Licensing Deals Tracker: Feb 2021
  • 4/5/2021SMEI: Performance Review of Drug Products Included in the NRDL through...
  • Page:206/789 Total number of articles:23668: [First][<<] [204] [205] [206] [207] [208] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group